Test Semiquantitative Prostate Specific Antigen (PSA)
NCT00853710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94
Last updated 2025-11-20
Summary
The aim of the study is to compare the diagnostic performances of a simple and rapid PSA assay on whole blood to the standard plasma PSA assay.
Conditions
- Prostate Cancer
- Prostatic Neoplasms
- Prostatic Diseases
Interventions
- OTHER
-
PSA assay
rapid prostate specific antigen assay.
Sponsors & Collaborators
-
Institut Curie
lead OTHER
Principal Investigators
-
Dominique BELLET, Pr · Institut Curie
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- France
Study Locations
More Related Trials
-
Korean Practice Patterns for Screening PCA(Prostate Cancer)
NCT01371513 ·Status: COMPLETED
-
Study of Diagnostic Performance of [18F]CTT1057 in BCR
NCT04838613 ·Status: COMPLETED ·Phase: PHASE3
-
MRI Prostate for Chinese Men Being Screened for Prostate Cancer
NCT03891732 ·Status: ACTIVE_NOT_RECRUITING
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
Adequacy of Prostate-Specific Antigen (PSA) Requests
NCT03968692 ·Status: UNKNOWN
-
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
NCT03957252 ·Status: ACTIVE_NOT_RECRUITING
-
PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer
NCT04983459 ·Status: COMPLETED
-
PSMA-Guided Ablation of the Prostate
NCT06003556 ·Status: RECRUITING ·Phase: PHASE2
-
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
NCT05160597 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946 ·Status: UNKNOWN ·Phase: NA
-
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage
NCT04116086 ·Status: UNKNOWN ·Phase: NA
-
Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study
NCT06987045 ·Status: NOT_YET_RECRUITING
-
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer
NCT04777071 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
NCT07109427 ·Status: RECRUITING ·Phase: NA
-
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485 ·Status: RECRUITING ·Phase: NA
-
Smart Prostate Specific Antigen (PSA) Screening Study
NCT04782713 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
NCT05948657 ·Status: RECRUITING ·Phase: NA
-
Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy
NCT04685928 ·Status: COMPLETED ·Phase: NA
-
PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial
NCT05297162 ·Status: UNKNOWN ·Phase: NA
-
68Ga-PSMA PET/CT in Prostate Cancer
NCT04684628 ·Status: SUSPENDED ·Phase: PHASE3
-
Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model
NCT05587192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
NCT06923657 ·Status: RECRUITING ·Phase: NA
-
The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer
NCT05958004 ·Status: COMPLETED
-
Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate Cancer
NCT03938766 ·Status: COMPLETED ·Phase: NA